1. Algazy, Jeffrey, et al. “A Vision for Medical Affairs 2030: Five Priorities for Patient Impact | McKinsey.” Www.mckinsey.com, 11 Oct. 2023, www.mckinsey.com/industries/life-sciences/our-insights/a-vision-for-medical-affairs-2030-five-priorities-for-patient-impact. 
2. American Cancer Society. “History of Cancer Screening and Early Detection: 20th Century to Present.” Www.cancer.org, 17 May 2021, www.cancer.org/cancer/understanding-cancer/history-of-cancer/screening-early-detection
3. Andrés Gómez‐De León, et al. “Acute Myeloid Leukemia: Challenges for Diagnosis and Treatment in Latin America.” Hematology, vol. 28, no. 1, 6 Jan. 2023, https://doi.org/10.1080/16078454.2022.2158015.
4. Ask the Doctors. “The Difference between Screening and Diagnostic Tests.” Www.uclahealth.org, 19 Aug. 2022, www.uclahealth.org/news/article/the-difference-between-screening-and-diagnostic-tests.
5. Bransky, Avishay, et al. “A Novel Approach to Hematology Testing at the Point of Care.” The Journal of Applied Laboratory Medicine, vol. 6, no. 2, 4 Dec. 2020, https://doi.org/10.1093/jalm/jfaa186.
6. Buford, Elisabeth. “10 Healthcare Technology Advancements in the Last Decade.” ReferralMD, 15 Feb. 2021, getreferralmd.com/10-healthcare-technology-advancements-in-the-last-decade/.
7. Children's Hospital of Philadelphia. “Pediatric Leukemias.” Chop.edu, 11 Sept. 2014, www.chop.edu/conditions-diseases/pediatric-leukemias.
8. Cleveland Clinic. “Fasting Blood Sugar: Screening Test for Diabetes.” Cleveland Clinic, 17 Oct. 2021, my.clevelandclinic.org/health/diagnostics/21952-fasting-blood-sugar.
9. Cleveland Clinic. “Leukemia Symptoms, Signs & Treatment Options.” Cleveland Clinic, 19 Nov. 2019, my.clevelandclinic.org/health/diseases/4365-leukemia.
10. “Conjugation Protocol for Amine Reactive Dyes.” Tocris Bioscience, 2017, www.tocris.com/resources/protocols/janelia-fluor-dyes/conjugation-protocol-amine-reactive-dyes. 
11. Dasgupta, Swati, et al. “Evaluation of a New Flow Cytometry Based Method for Detection of BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia.” Blood Research, vol. 52, no. 2, June 2017, pp. 112–118, pubmed.ncbi.nlm.nih.gov/28698847/, https://doi.org/10.5045/br.2017.52.2.112.
12. Dekking, E., et al. “Detection of Fusion Genes at the Protein Level in Leukemia Patients via the Flow Cytometric Immunobead Assay.” Best Practice & Research Clinical Haematology, vol. 23, no. 3, 1 Sept. 2010, pp. 333–345, https://doi.org/10.1016/j.beha.2010.09.010. 
13. Elrobaa, Islam H, et al. “The Role of Point-of-Care Testing to Improve Acute Care and Health Care Services.” Cureus, vol. 16, no. 3, 2024, p. e55315, www.ncbi.nlm.nih.gov/pmc/articles/PMC10905651/, https://doi.org/10.7759/cureus.55315.
14. Farroni, Jeffery S, et al. “Ethical Issues in Patients with Leukemia: Practice Points and Educational Topics for the Clinical...” ResearchGate, OMICS Publishing Group, 2017, www.researchgate.net/publication/320764682
15. “FluoroTag FITC Conjugation Kit.” Dec. 2021.
16. Hayashi-Takanaka, Yoko, et al. “Evaluation of Chemical Fluorescent Dyes as a Protein Conjugation Partner for Live Cell Imaging.” PLoS ONE, vol. 9, no. 9, 3 Sept. 2014, p. e106271, https://doi.org/10.1371/journal.pone.0106271. 
17. Hemarajata, Peera. “A Brief History of Laboratory Diagnostics for Syphilis.” ASM.org, 6 Jan. 2020, asm.org/Articles/2020/January/A-Brief-History-of-Laboratory-Diagnostics-for-Syph.
18. “Interdisciplinary.” K-State.edu, 2024, cancer.k-state.edu/research/interdiciplinaryinitiatives/. Accessed 23 Jan. 2025.
19. “Interdisciplinary Teams Addressing Social Risks in Cancer Care Webinar Series.” Healthcaredelivery.cancer.gov, 17 Jan. 2025, healthcaredelivery.cancer.gov/social-risks/webinar-series/interdisciplinary-teams-webinar-series.html.
20. John Hopkins Medicine. “Screening Tests for Common Diseases.” John Hopkins Medicine, 2019, www.hopkinsmedicine.org/health/treatment-tests-and-therapies/screening-tests-for-common-diseases.
21. Kudra, Ray. “Point-of-Care Testing: Bring the Benefits to Your MD Office - Medline.” Medline, 30 Apr. 2024, www.medline.com/strategies/lab/point-of-care-testing-benefits-physician-offices/
22. Klein, Sarah. “How to Cope with the Financial Toll of Cancer.” TIME, Time, 3 June 2024, time.com/6984939/cancer-costs-how-to-cope/.
23. Knutson, Steve, et al. “Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.” PLOS ONE, vol. 11, no. 6, 23 June 2016, p. e0157762, https://doi.org/10.1371/journal.pone.0157762. 
24. Lakhtakia, Ritu. “The History of Diabetes Mellitus .” Sultan Qaboos University Medical Journal, vol. 13, no. 3, Aug. 2013, pp. 368–370, www.ncbi.nlm.nih.gov/pmc/articles/PMC3749019/, https://doi.org/10.12816/0003257.
25. LicorBio. “Visible Fluorescent Protein Labeling Kits.” Licorbio.com, shop.licor.com/bio/reagents/visible-fluorescence-protein-labeling-kits.
26. Marcucci, Guido. “Leukemia Diagnosis and Staging.” City of Hope, 15 Apr. 2024, www.cityofhope.org/clinical-program/leukemia/diagnosis-staging.
27. Marron, Jonathan M. “Informed Consent for Genetic Testing in Hematology.” Ashpublications.org, 2023, ashpublications.org/hematology/article/2020/1/213/474311/Informed-consent-for-genetic-testing-in-hematology. 
28. Mayo Clinic. “Leukemia - Symptoms and Causes.” Mayo Clinic, 21 Sept. 2022, www.mayoclinic.org/diseases-conditions/leukemia/symptoms-causes/syc-20374373.
29. Mayo Clinic Staff. “BCRAB - Overview: BCR/ABL1, P210, MRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Chronic Myeloid Leukemia (CML), Varies.” Mayo Clinic Laboratories, 2015, www.mayocliniclabs.com/test-catalog/overview/89007. 
30. Moe, Simon. “Considerations for Selecting a Fluorescent Dye or Ligand.” Promega.com, 2022, www.promega.com/resources/pubhub/2024/considerations-for-selecting-a-fluorescent-dye-or-ligand/. 
31. Moffitt Cancer Center. “Leukemia Screening.” Moffitt, 2025, www.moffitt.org/cancers/leukemia/diagnosis/screening/.
32. Morabia, A, and F Zhang. “History of Medical Screening: From Concepts to Action.” Postgraduate Medical Journal, vol. 80, no. 946, 1 Aug. 2004, pp. 463–469, https://doi.org/10.1136/pgmj.2003.018226. 
33. Needle.Tube. “Needle.Tube - Diagnostic Lab Supplies, Great Prices, Fast Delivery, Blood Collection Needles, Blood Collection Tubes, Infusion Needles.” Needle.Tube - Diagnostic Lab Supplies, Great Prices, Fast Delivery, Blood Collection Needles, Blood Collection Tubes, Infusion Needles, 9 May 2024, www.needle.tube/product-articles-9/benefits-of-capillary-blood-collection-tubes-design-function-and-advantages. Accessed 29 Jan. 2025.
34. Ning, Liqing, et al. “Trends in Disease Burden of Chronic Myeloid Leukemia at the Global, Regional, and National Levels: A Population-Based Epidemiologic Study.” Experimental Hematology & Oncology, vol. 9, no. 1, 3 Nov. 2020, https://doi.org/10.1186/s40164-020-00185-z.
35. Pathology Tests Explained. “BCR-ABL 1 | Pathology Tests Explained.” Pathologytestsexplained.org.au, 1 June 2023, pathologytestsexplained.org.au/ptests-pro.php?q=BCR-ABL+1.
36. “Rapid Antigen Test.” Wikipedia, 31 May 2021, en.wikipedia.org/wiki/Rapid_antigen_test.
37. “Rapid Tests: MedlinePlus Medical Test.” Medlineplus.gov, 4 Sept. 2024, medlineplus.gov/lab-tests/rapid-tests/.
38. Roche. “Roche | the History - and Future - of Blood Glucose Monitoring.” Www.roche.com, 12 June 2023, www.roche.com/stories/diabetes-history
39. Ruchlemer, Rosa, and Aaron Polliack. “Geography, Ethnicity and “Roots” in Chronic Lymphocytic Leukemia.” Leukemia & Lymphoma, vol. 54, no. 6, 10 Dec. 2012, pp. 1142–1150, https://doi.org/10.3109/10428194.2012.740670. 
40. Shmerling, Robert H. “Screening Tests May Save Lives — so When Is It Time to Stop?” Harvard Health, 23 Jan. 2023, www.health.harvard.edu/blog/screening-tests-may-save-lives-so-when-is-it-time-to-stop-202301232879.
41. School of Health Professions. “A Brief History of Medical Testing.” Ttuhsc.edu, 2022, dailydose.ttuhsc.edu/2022/february/history-of-medical-testing.aspx. 
42. ScienceDirect. “Fusion Protein - an Overview | ScienceDirect Topics.” Www.sciencedirect.com, 2001, www.sciencedirect.com/topics/neuroscience/fusion-protein.
43. ScienceDirect. “Capillary Tube - an Overview | ScienceDirect Topics.” Www.sciencedirect.com, 2017, www.sciencedirect.com/topics/nursing-and-health-professions/capillary-tube.
44. ThermoFisher Editors. “Amine-Reactive Probe Labeling Protocol | Thermo Fisher Scientific - US.” Thermofisher.com, 2024, www.thermofisher.com/de/de/home/references/protocols/cell-and-tissue-analysis/labeling-chemistry-protocols/amine-reactive-probe-labeling-protocol.html. 
45. Tudor, Maria E, et al. “Syphilis.” Nih.gov, StatPearls Publishing, 2023, www.ncbi.nlm.nih.gov/books/NBK534780/.
46. Uyl-de Groot, C A, et al. “Costs of Diagnosis, Treatment, and Follow up of Patients with Acute Myeloid Leukemia in the Netherlands.” Journal of Hematotherapy & Stem Cell Research, vol. 10, no. 1, 2001, pp. 187–92, www.ncbi.nlm.nih.gov/pubmed/11276372, https://doi.org/10.1089/152581601750098499.
47. White, Tim, and Sara Algeri. “Estimating the Lifetime Risk of a False Positive Screening Test Result.” PLOS ONE, vol. 18, no. 2, 15 Feb. 2023, p. e0281153, https://doi.org/10.1371/journal.pone.0281153.
48. Wong, Stanley S. C., and Kevin Truong. “Fluorescent Protein-Based Methods for On-Plate Screening of Gene Insertion.” PLoS ONE, vol. 5, no. 12, 10 Dec. 2010, p. e14274, https://doi.org/10.1371/journal.pone.0014274.
49. Yale Medicine. “Diagnosing Leukemia.” Yale Medicine, www.yalemedicine.org/conditions/leukemia-diagnosis. Accessed 23 Jan. 2025.
50. Yeoh, Allen E J, et al. “Management of Adult and Paediatric Acute Lymphoblastic Leukaemia in Asia: Resource-Stratified Guidelines from the Asian Oncology Summit 2013.” The Lancet Oncology, vol. 14, no. 12, Nov. 2013, pp. e508–e523, https://doi.org/10.1016/s1470-2045(13)70452-2.